The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2023

Filed:

Jun. 15, 2017
Applicant:

Yale University, New Haven, CT (US);

Inventors:

Jiangbing Zhou, Cheshire, CT (US);

James Hansen, Guilford, CT (US);

Assignee:

YALE UNIVERSITY, New Haven, CT (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61P 35/00 (2006.01); A61K 47/68 (2017.01); A61K 31/502 (2006.01); A61K 31/704 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6937 (2017.08); A61K 31/502 (2013.01); A61K 31/704 (2013.01); A61K 47/6843 (2017.08); A61K 47/6935 (2017.08); A61P 35/00 (2018.01);
Abstract

DNA-targeted nanocarriers for encapsulating an active agent and delivering it to extracellular DNA are provided. The nanocarriers, for example, polymeric particles, liposomes, and multilamellar vesicles have targeting moiety that targets DNA conjugated thereto. The targeting moiety that targets DNA is typically an antibody, or variant, fragment, or fusion protein derived therefrom that binds to DNA or nucleosomes. The targeting moiety can be a circulating autoantibody that binds DNA such as those commonly found in patients with SLE. In some embodiments, the targeting moiety is antibody 3E10 or a variant, fragment, or fusion protein derived therefrom. Pharmaceutical compositions, methods of use, and dosage regimens are also provided.


Find Patent Forward Citations

Loading…